Clinical Trials Browser

OTHER × Liver Neoplasms × Immunotherapy × Clear all

NCT04707547 2021-01-13

RFA

Phase 4 Completed

Gastrointestinal

Liver Neoplasms

NCT02989870 2020-06-05

Sorafenib and Bavituximab Plus SBRT in Unresectable Hepatocellular Carcinoma

Phase 1 Withdrawn

Gastrointestinal

Carcinoma, Hepatocellular, Liver Diseases, Liver Neoplasms